Amy Lim
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
-
- Immunotherapy and Immune Responses
- Toxin Mechanisms and Immunotoxins
Papers in
-
- Protein purification and stability 3
- Viral Infectious Diseases and Gene Expression in Insects 2
- Virology 5
- HIV Research and Treatment 5
- Co-authors
- Michael F. Powell (8 shared papers)Jeffrey L. Cleland (7 shared papers)Charlotte R. Kensil (4 shared papers)Neil E. Jacobsen (2 shared papers)Lorena Barrón (4 shared papers)Wayne J. Fairbrother (1 shared paper)Eileen Duenas (3 shared papers)Phillip W. Berman (4 shared papers)
- Journals
- Journal of Pharmaceutical Sciences (4 papers)Pharmaceutical Research (1 paper)Microbial Cell Factories (1 paper)AIDS Research and Human Retroviruses (1 paper)Biotechnology Progress (1 paper)
- Partner nations
- United States
In The Last Decade
Amy Lim
12 papers receiving 416 citations
Peers
Comparison fields: 5 of 69
- Pharmaceutical Science 80
- Immunology 175
- Virology 34
- Molecular Biology 300
- Pharmacology 23
Countries citing papers authored by Amy Lim
This map shows the geographic impact of Amy Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Lim more than expected).
Fields of papers citing papers by Amy Lim
This network shows the impact of papers produced by Amy Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Lim. The network helps show where Amy Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 96 | |
| 2 | 1996 | 73 | |
| 3 | 1997 | 66 | |
| 4 | 2013 | 53 | |
| 5 | 1996 | 39 | |
| 6 | 1995 | 38 | |
| 7 | 1996 | 26 | |
| 8 | 1998 | 24 | |
| 9 | 1995 | 19 | |
| 10 | Inhibition of cMet activation by a one-armed antibody | 2004 | 10 |
| 11 | 2006 | 2 | |
| 12 | A test for differential diagnosis between vaccinated cattle and those with brucellosis. | 1990 | 1 |
About Amy Lim
Amy Lim is a scholar working on Molecular Biology, Virology, Epidemiology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 447 indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), Protein purification and stability (3 papers), Herpesvirus Infections and Treatments (3 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Drug Solubulity and Delivery Systems (1 paper). The work is most often cited by research in Pharmaceutical Science (80 citations), Immunology (175 citations), Virology (34 citations), Molecular Biology (300 citations) and Pharmacology (23 citations). Amy Lim has collaborated with scholars based in United States. Frequent co-authors include Michael F. Powell, Jeffrey L. Cleland, Charlotte R. Kensil, Neil E. Jacobsen, Lorena Barrón, Wayne J. Fairbrother, Eileen Duenas, Phillip W. Berman, Terri Wrin and Joann Vennari. Their work appears in journals such as Journal of Pharmaceutical Sciences, Pharmaceutical Research, Microbial Cell Factories, AIDS Research and Human Retroviruses and Biotechnology Progress.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.